S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

LCTX Lineage Cell Therapeutics Inc

0.6594

0.018 (2.81%)

Pre Market

Last Updated: 06:40:23

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics Inc News

Form 8-K - Current report
Wednesday 20 November 2024 (15 hours ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Wednesday 20 November 2024 (1 day ago) • Business Wire

Form 8-K - Current report
Thursday 14 November 2024 (7 days ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Thursday 14 November 2024 (7 days ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
Thursday 7 November 2024 (2 weeks ago) • Business Wire

Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
Monday 14 October 2024 (1 month ago) • Business Wire

OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
Wednesday 25 September 2024 (2 months ago) • Business Wire

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
Wednesday 18 September 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Monday 19 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (3 months ago) • Edgar (US Regulatory)

More Lineage Cell Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions